Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Cash from Investing Activities (2021 - 2025)

P3 Health Partners' Cash from Investing Activities history spans 5 years, with the latest figure at $198000.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 141.68% year-over-year to $198000.0; the TTM value through Dec 2025 reached $129000.0, down 99.11%, while the annual FY2025 figure was $129000.0, 99.11% down from the prior year.
  • Cash from Investing Activities reached $198000.0 in Q4 2025 per PIIIW's latest filing, up from -$119000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $15.0 million in Q3 2024 to a low of -$6.4 million in Q3 2022.
  • Average Cash from Investing Activities over 5 years is -$183235.3, with a median of -$387000.0 recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: tumbled 371.43% in 2023, then skyrocketed 3975.97% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$324833.0 in 2021, then surged by 115.39% to $50000.0 in 2022, then skyrocketed by 324.0% to $212000.0 in 2023, then tumbled by 324.06% to -$475000.0 in 2024, then surged by 141.68% to $198000.0 in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Cash from Investing Activities are $198000.0 (Q4 2025), -$119000.0 (Q3 2025), and $50000.0 (Q2 2025).